Nguyen Thuy, German Nadezhda, Decker Ann M, Li Jun-Xu, Wiley Jenny L, Thomas Brian F, Kenakin Terry P, Zhang Yanan
Research Triangle Institute, Research Triangle Park, North Carolina 27709, United States.
Department of Pharmacology and Toxicology, University at Buffalo, the State University of New York, Buffalo, New York 14214, United States.
Bioorg Med Chem. 2015 May 1;23(9):2195-2203. doi: 10.1016/j.bmc.2015.02.058. Epub 2015 Mar 7.
A series of substituted 1H-indole-2-carboxamides structurally related to compounds Org27569 (1), Org29647 (2) and Org27759 (3) were synthesized and evaluated for CB1 allosteric modulating activity in calcium mobilization assays. Structure-activity relationship studies showed that the modulation potency of this series at the CB1 receptor was enhanced by the presence of a diethylamino group at the 4-position of the phenyl ring, a chloro or fluoro group at the C5 position and short alkyl groups at the C3 position on the indole ring. The most potent compound (45) had an IC₅₀ value of 79 nM which is ∼2.5 and 10 fold more potent than the parent compounds 3 and 1, respectively. These compounds appeared to be negative allosteric modulators at the CB1 receptor and dose-dependently reduced the Emax of agonist CP55,940. These analogs may provide the basis for further optimization and use of CB1 allosteric modulators.
合成了一系列与化合物Org27569(1)、Org29647(2)和Org27759(3)结构相关的取代1H-吲哚-2-甲酰胺,并在钙动员试验中评估了它们对CB1变构调节活性。构效关系研究表明,该系列化合物在CB1受体上的调节效力通过苯环4位上的二乙氨基、吲哚环C5位上的氯或氟基团以及吲哚环C3位上的短烷基的存在而增强。最有效的化合物(45)的IC₅₀值为79 nM,分别比母体化合物3和1强约2.5倍和10倍。这些化合物似乎是CB1受体的负性变构调节剂,并且剂量依赖性地降低了激动剂CP55,940的Emax。这些类似物可为CB1变构调节剂的进一步优化和应用提供基础。